![](/img/cover-not-exists.png)
Does Adding Ribavirin to Newer Direct-Acting Antiviral (DAA) Regimens Affect Sustained Virologic Response (SVR) Rates in Hepatitis C Virus (HCV)-Infected Persons in Actual Clinical Settings? Results From ERCHIVES
Butt, Adeel, Yan, Peng, Marks, Kristen M., Shaikh, Obaid, Sherman, KennethVolume:
3
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofw172.305
Date:
December, 2016
File:
PDF, 113 KB
english, 2016